Taiwanese Pharmaceuticals & Biotech High And Sustainable

Results

0 new

Companies in a sound financial shape with a dividend yield of more than 5%.

3 companies

PharmaEngine

Market Cap: NT$12.1b

A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.

4162

NT$84.10

-14.9%

-14.1%

TTY Biopharm

Market Cap: NT$17.8b

Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan and internationally.

4105

NT$71.40

-5.7%

-8.7%

SYN-TECH Chem. & Pharm

Market Cap: NT$4.0b

Manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally.

1777

NT$90.20

-12.0%

8.9%